337 related articles for article (PubMed ID: 5577487)
1. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
[No Abstract] [Full Text] [Related]
2. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
Andrews CJ; Somerville B
Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
[No Abstract] [Full Text] [Related]
3. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
Christiani K; Möller WD
Munch Med Wochenschr; 1973 Apr; 115(16):711-3. PubMed ID: 4197759
[No Abstract] [Full Text] [Related]
4. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Introduction.
McDowell F
Clin Pharmacol Ther; 1971; 12(2):317-8. PubMed ID: 5577479
[No Abstract] [Full Text] [Related]
5. [Dopa and decarboxylase inhibitors in Parkinson's disease].
Pakkenberg H
Ugeskr Laeger; 1974 Feb; 136(7):377. PubMed ID: 4821980
[No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease with levodopa and Ro 4-4602.
Barbeau A; Gillo-Joffroy L; Mars H
Clin Pharmacol Ther; 1971; 12(2):353-9. PubMed ID: 4930866
[No Abstract] [Full Text] [Related]
7. Metabolic interactions of pyridoxine, levodopa, and carbidopa in Parkinson's disease.
Mars H
Trans Am Neurol Assoc; 1973; 98():241-5. PubMed ID: 4784941
[No Abstract] [Full Text] [Related]
8. MK 486 and levodopa in treatment of Parkinsonism.
Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F
Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885
[No Abstract] [Full Text] [Related]
9. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
Pletscher A; Bartholini G; Gey KF; Jenni A
Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
[No Abstract] [Full Text] [Related]
10. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).
Yahr MD; Duvoisin RC; Mendoza MR; Schear MJ; Barrett RE
Trans Am Neurol Assoc; 1971; 96():55-8. PubMed ID: 5159129
[No Abstract] [Full Text] [Related]
11. Long-term treatment of Parkinson's disease with levodopa.
Campbell JB
Neurology; 1970 Dec; 20(12):18-22. PubMed ID: 5531291
[No Abstract] [Full Text] [Related]
12. [Parkinson's syndrome. 4 years of experience in treatment with L Dopa associated with a decarboxylase inhibitor. Clinical and biochemical study].
Tissot R; de Ajuriaguerra J
Nouv Presse Med; 1973 Feb; 2(5):315-6. PubMed ID: 4686226
[No Abstract] [Full Text] [Related]
13. Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
Sweet RD; Lee JE; McDowell F
Trans Am Neurol Assoc; 1971; 96():59-65. PubMed ID: 5159130
[No Abstract] [Full Text] [Related]
14. [Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Steinhäusl H
Wien Med Wochenschr; 1973 Jun; 123(26):433-5. PubMed ID: 4578743
[No Abstract] [Full Text] [Related]
15. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
Clin Pharmacol Ther; 1970; 11(6):921-4. PubMed ID: 4921295
[No Abstract] [Full Text] [Related]
16. [Treatment of Parkinson's disease with levodopa].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
[No Abstract] [Full Text] [Related]
17. Reappraisal of levodopa therapy for Parkinson's disease. A three-year experience with outpatients in private practice.
McFarland HR
Mo Med; 1974 Sep; 71(9):535-7. PubMed ID: 4854038
[No Abstract] [Full Text] [Related]
18. [Medical treatment of Parkinson's disease].
Castaigne P; Rondot P; Ribadeau-Dumas JL
Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040
[No Abstract] [Full Text] [Related]
19. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
[No Abstract] [Full Text] [Related]
20. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Clinical laboratory abnormalities.
McDowell F
Clin Pharmacol Ther; 1971; 12(2):335-9. PubMed ID: 4102803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
